Physician profile
Kayla Smith
NPI 1699039529
$3,465.58
in general payments reported to CMS, 2019-2025
19 companies · $460 in 2025
The $460 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2020: $11.31 · 2021: $375 · 2022: $246 · 2023: $1,457 · 2024: $745 · 2025: $460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,442 · Travel and Lodging: $1,220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,442.15 |
| Travel and Lodging | $1,219.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,346.91 | 2023 | |
| Kerecis Limited | $536.40 | 2021-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Mentor Worldwide LLC | $438.99 | 2019-2025 | Artoura Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer |
| Abbvie INC. | $271.39 | 2024-2025 | |
| Musculoskeletal Transplant Foundation INC. | $189.37 | 2021-2023 | |
| Boston Scientific Corporation | $145.13 | 2024 | Wavewriter Alpha Prime 16 |
| Motiva USA, LLC | $144.09 | 2025 | |
| Sientra, INC. | $98.11 | 2020-2022 | |
| Axogen | $49.20 | 2025 | |
| Galderma Laboratories, L.P. | $39.62 | 2019 | |
| Polynovo North America LLC | $35.43 | 2022-2023 | |
| Halozyme INC | $27.79 | 2024-2025 | Hylenex Recombinant |
| Kci USA, INC. | $25.92 | 2021 | |
| Solventum Corporation | $23.55 | 2025 | Prevena, Activ.A.C., V.A.C.Instill |
| Convatec INC. | $22.97 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $21.88 | 2025 | Dexcom G6 Transmitter |
| Tela Bio, INC. | $19.27 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Tanabe Pharma America, INC. | $14.86 | 2019 | |
| Integra Lifesciences Corporation | $14.70 | 2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kayla Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.